Hemocompatibility of n-trimethyl chitosan chloride nanoparticles
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-065
- By: DU PLESSIS, Lissinda (North-West University, Potchefstroom campus, Pharmaceutics, Potchefstroom, South Africa)
- Co-author(s): Du Toit, Lizl (North-West University, Potchefstroom campus, Potchefstroom, South Africa)
Steenekamp, Jan (North-West University, Potchefstroom campus, Potchefstroom, South Africa)
Background: N-trimethyl chitosan chloride (TMC) is a cationic water soluble derivative of chitosan, used as an intravenous drug delivery system for gene, vaccine and anti-cancer delivery. Its cytotoxicity has been extensively studied, but there is a lack of information about the hemocomapitiblity.
Aim: This study evaluates the hemocompatibility of .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.